CERo Therapeutics Holdings, Inc.
USD0.01
-0.00 (-7.69%)
CEO
Christopher Ehrlich
IPO Date
2021-11-30
Sector
Healthcare
Industry
Biotechnology
Exchange
OTC
Country
US
Open
$0.01
Prev. Close
$0.01
Day Low
$0.01
Day High
$0.01
52W Low
$0.01
52W High
$26.99
Market Cap
$0.00B
Volume
0.55M
| 0 |
| $0.00 |
| 9 Jan 2026 | Rolfe Lindsey | director | A-Award | Acquired | 690,900 | $0.06 |
| 9 Jan 2026 | LAPORTE KATHLEEN | director | A-Award | Acquired | 690,900 | $0.06 |
| 9 Jan 2026 | Pierce Kristen | Chief Development Officer | A-Award | Acquired | 1,612,099 | $0.06 |
| 9 Jan 2026 | Patel Shami | director | A-Award | Acquired | 690,900 | $0.06 |
| 9 Jan 2026 | ATWOOD BRIAN G | director | A-Award | Acquired | 1,612,099 | $0.06 |
| 9 Jan 2026 | Ehrlich Christopher B | director, officer: Chairman and CEO | A-Award | Acquired | 4,530,997 | $0.06 |
| 9 Jan 2026 | Byrnes Michael | director | A-Award | Acquired | 690,900 | $0.06 |
| 9 Jan 2026 | KUCHARCHUK ANDREW ALBERT | Chief Financial Officer | A-Award | Acquired | 1,162,099 | $0.06 |